8.21
6.76%
0.52
Oric Pharmaceuticals Inc Azioni (ORIC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
7.76%
28.99
|
31.43 | 28.68 | 24.99 | 25.68 |
Operating Income/Loss |
7.76%
-28.99
|
-31.43 | -28.68 | -24.99 | -25.68 |
Nonoperating Income/Loss |
28.44%
3.979
|
3.098 | 3.204 | 2.048 | 1.733 |
Income/Loss From Continuing Operations Before Tax |
11.72%
-25.01
|
-28.33 | -25.48 | -22.94 | -23.95 |
Income/Loss From Continuing Operations After Tax |
11.72%
-25.01
|
-28.33 | -25.48 | -22.94 | -23.95 |
Net Income/Loss
|
11.72%
-25.01
|
-28.33 | -25.48 | -22.94 | -23.95 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,224%
67.35
|
2.0264 | 57.40 | 45.65 | 45.09 |
Diluted Average Shares |
3,224%
67.35
|
2.0264 | 57.40 | 45.65 | 45.09 |
Basic Earnings Per Share |
26.00%
-0.37
|
-0.50 | -0.44 | -0.50 | -0.53 |
Diluted Earnings Per Share |
26.00%
-0.37
|
-0.50 | -0.44 | -0.50 | -0.53 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):